This will be discussed with you prior to discharge from the hospital
Is MOTS-c a GLP-1 medication
Inclusion criteria This review considered peer-reviewed studies of L-carnitine supplementation in subjects with coronary artery disease across predefined designs, each with a distinct role, including preclinical evidence such as animal studies which provided mechanistic evidence and insights on emerging pathways, as well as clinical evidence such as case reports, cross-sectional studies, observational studies, retrospective analyses, randomized controlled trials, systematic review and meta-analyses which provided primary evidence as well as quantitative analysis of clinical endpoints
In experimental settings, this has been associated with improved cell survival, migration, and wound-healing activity
Specific reductions at day 14 included 2.3 points for the AM-301 group and 0.61 points for the saline spray group